Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expression
1995615 citationsLaurie B. Owen‐Schaub, Wei Zhang et al.Molecular and Cellular Biologyprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Ewa Kruzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Kruzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Kruzel more than expected).
This network shows the impact of papers produced by Ewa Kruzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Kruzel. The network helps show where Ewa Kruzel may publish in the future.
Co-authorship network of co-authors of Ewa Kruzel
This figure shows the co-authorship network connecting the top 25 collaborators of Ewa Kruzel.
A scholar is included among the top collaborators of Ewa Kruzel based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Ewa Kruzel. Ewa Kruzel is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Fan, Dominic, Seiji Yano, Hisashi Shinohara, et al.. (2002). Targeted therapy against human lung cancer in nude mice by high-affinity recombinant antimesothelin single-chain Fv immunotoxin.. PubMed. 1(8). 595–600.36 indexed citations
4.
Owen‐Schaub, Laurie B., Wei Zhang, James C. Cusack, et al.. (1995). Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expression. Molecular and Cellular Biology. 15(6). 3032–3040.615 indexed citations breakdown →
5.
Owen‐Schaub, Laurie B., Robert Radinsky, Ewa Kruzel, K. K. Berry, & Shin Yonehara. (1994). Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness.. PubMed. 54(6). 1580–6.237 indexed citations
Klinger, M, et al.. (1980). The influence of uremic sera on the blastic transformation of lymphocytes of healthy subjects, stimulated with non-specific mitogens (PHA, con A, PWM).. PubMed. 28(1). 73–82.2 indexed citations
8.
Klinger, M, et al.. (1978). Subpopulations of T and B lymphocytes in peripheral blood and lymphocytes reactivity to non-specific mitogens (PHA, Con A, PWM) in in vitro cultures in patients suffering from in vitro cultures in patients suffering from glomerulonephritis.. PubMed. 26(1-6). 289–94.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.